Global Colorectal Cancer Drugs Market Outlook 2021

Publication ID:

QYR11200147

Publication Date:

November 23, 2020

Pages:

121

Publisher:

QYR

Region:

Global [1]

$2,900.00

Description:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment , the Colorectal Cancer Drugs market is segmented into
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators

Segment
Radiotherapy
Chemotherapy

Global Colorectal Cancer Drugs Market: Regional Analysis
The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast and segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Colorectal Cancer Drugs market report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Colorectal Cancer Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Colorectal Cancer Drugs market include:
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen

Table Of Contents:

1 Colorectal Cancer Drugs Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Drugs
1.2 Colorectal Cancer Drugs Segment
1.2.1 Global Colorectal Cancer Drugs Sales Growth Rate Comparison (2021-2026)
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Colorectal Cancer Drugs Segment
1.3.1 Colorectal Cancer Drugs Sales Comparison : 2020 VS 2026
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Colorectal Cancer Drugs Revenue 2015-2026
1.4.2 Global Colorectal Cancer Drugs Sales 2015-2026
1.4.3 Colorectal Cancer Drugs Market Size by Region: 2020 Versus 2026
1.5 Colorectal Cancer Drugs Industry
1.6 Colorectal Cancer Drugs Market Trends

2 Global Colorectal Cancer Drugs Market Competition by Manufacturers
2.1 Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Colorectal Cancer Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Colorectal Cancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Colorectal Cancer Drugs Market Competitive Situation and Trends
2.5.1 Colorectal Cancer Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)

3 Colorectal Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Colorectal Cancer Drugs Market Facts & Figures by Country
3.3.1 North America Colorectal Cancer Drugs Sales by Country
3.3.2 North America Colorectal Cancer Drugs Sales by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Colorectal Cancer Drugs Market Facts & Figures by Country
3.4.1 Europe Colorectal Cancer Drugs Sales by Country
3.4.2 Europe Colorectal Cancer Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Colorectal Cancer Drugs Sales by Region
3.5.2 Asia Pacific Colorectal Cancer Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Colorectal Cancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Colorectal Cancer Drugs Sales by Country
3.6.2 Latin America Colorectal Cancer Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country
3.7.2 Middle East and Africa Colorectal Cancer Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Colorectal Cancer Drugs Historic Market Analysis
4.1 Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
4.2 Global Colorectal Cancer Drugs Revenue Market Share (2015-2020)
4.3 Global Colorectal Cancer Drugs Price Market Share (2015-2020)
4.4 Global Colorectal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Colorectal Cancer Drugs Historic Market Analysis
5.1 Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
5.2 Global Colorectal Cancer Drugs Revenue Market Share (2015-2020)
5.3 Global Colorectal Cancer Drugs Price (2015-2020)

6 Company Profiles and Key Figures in Colorectal Cancer Drugs Business
6.1 AB Science
6.1.1 Corporation Information
6.1.2 AB Science Description, Business Overview and Total Revenue
6.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AB Science Products Offered
6.1.5 AB Science Recent Development
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description, Business Overview and Total Revenue
6.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Amgen Products Offered
6.2.5 Amgen Recent Development
6.3 Array BioPharma
6.3.1 Array BioPharma Corporation Information
6.3.2 Array BioPharma Description, Business Overview and Total Revenue
6.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Array BioPharma Products Offered
6.3.5 Array BioPharma Recent Development
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description, Business Overview and Total Revenue
6.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bayer Products Offered
6.4.5 Bayer Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bristol-Myers Squibb Products Offered
6.6.5 Bristol-Myers Squibb Recent Development
6.7 Elli Lilly
6.6.1 Elli Lilly Corporation Information
6.6.2 Elli Lilly Description, Business Overview and Total Revenue
6.6.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Elli Lilly Products Offered
6.7.5 Elli Lilly Recent Development
6.8 Roch
6.8.1 Roch Corporation Information
6.8.2 Roch Description, Business Overview and Total Revenue
6.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Roch Products Offered
6.8.5 Roch Recent Development
6.9 Hutchison MediPharma
6.9.1 Hutchison MediPharma Corporation Information
6.9.2 Hutchison MediPharma Description, Business Overview and Total Revenue
6.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hutchison MediPharma Products Offered
6.9.5 Hutchison MediPharma Recent Development
6.10 Merck & Co., Inc.
6.10.1 Merck & Co., Inc. Corporation Information
6.10.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
6.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Merck & Co., Inc. Products Offered
6.10.5 Merck & Co., Inc. Recent Development
6.11 Mologen
6.11.1 Mologen Corporation Information
6.11.2 Mologen Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Mologen Products Offered
6.11.5 Mologen Recent Development
6.12 Regeneron
6.12.1 Regeneron Corporation Information
6.12.2 Regeneron Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Regeneron Products Offered
6.12.5 Regeneron Recent Development
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Sanofi Products Offered
6.13.5 Sanofi Recent Development
6.14 Sumitomo Dainippon
6.14.1 Sumitomo Dainippon Corporation Information
6.14.2 Sumitomo Dainippon Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Sumitomo Dainippon Products Offered
6.14.5 Sumitomo Dainippon Recent Development
6.15 Taiho Pharmaceutical
6.15.1 Taiho Pharmaceutical Corporation Information
6.15.2 Taiho Pharmaceutical Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Taiho Pharmaceutical Products Offered
6.15.5 Taiho Pharmaceutical Recent Development
6.16 Vaccinogen
6.16.1 Vaccinogen Corporation Information
6.16.2 Vaccinogen Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Vaccinogen Products Offered
6.16.5 Vaccinogen Recent Development

7 Colorectal Cancer Drugs Manufacturing Cost Analysis
7.1 Colorectal Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Colorectal Cancer Drugs
7.4 Colorectal Cancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Colorectal Cancer Drugs Distributors List
8.3 Colorectal Cancer Drugs Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Colorectal Cancer Drugs Market Estimates and Projections
10.1.1 Global Forecasted Sales of Colorectal Cancer Drugs (2021-2026)
10.1.2 Global Forecasted Revenue of Colorectal Cancer Drugs (2021-2026)
10.2 Colorectal Cancer Drugs Market Estimates and Projections
10.2.1 Global Forecasted Sales of Colorectal Cancer Drugs (2021-2026)
10.2.2 Global Forecasted Revenue of Colorectal Cancer Drugs (2021-2026)
10.3 Colorectal Cancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Colorectal Cancer Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Colorectal Cancer Drugs by Region (2021-2026)
10.4 North America Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.5 Europe Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.7 Latin America Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Colorectal Cancer Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Companies Mentioned:

AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.